| Line Item | 2023-05-31 | Y/Y |
|---|---|---|
| Revenue | $49.95B | +17.7% |
| R&D Expense | $8.62B | +19.4% |
| SG&A Expense | $1.58B | +19.9% |
| Operating Income | $13.09B | +19.8% |
| Interest Expense | $3.50B | +27.2% |
| Income Tax | $623.0M | -33.2% |
| Net Income | $8.50B | +26.6% |
| EPS (Basic) | $3.15 | +26.5% |
| EPS (Diluted) | $3.07 |
| Line Item | 2023-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.77B | -54.3% |
| Accounts Receivable | $6.92B | +16.2% |
| Inventory | $298.0M | -5.1% |
| Current Assets | $21.00B | -33.6% |
| Total Assets | $134.38B | +23.0% |
| Current Liabilities | $23.09B | +18.3% |
| Stockholders' Equity | $1.07B | +117.3% |
| Line Item | 2023-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $17.16B | +79.9% |
| Capital Expenditures | $8.70B | +92.8% |
| Investing Cash Flow | -$36.48B | -425.2% |
| Financing Cash Flow | $7.91B | +127.2% |
| Free Cash Flow | $8.47B | +68.5% |
| +27.4% |